Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Net Cash Flow (2016 - 2025)

Sangamo Therapeutics (SGMO) has disclosed Net Cash Flow for 16 consecutive years, with -$9.6 million as the latest value for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 293.8% year-over-year to -$9.6 million; the TTM value through Dec 2025 reached -$26.6 million, down 2045.48%, while the annual FY2025 figure was -$26.6 million, 2045.48% down from the prior year.
  • Net Cash Flow hit -$9.6 million in Q4 2025 for Sangamo Therapeutics, down from -$9.4 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $46.8 million in Q2 2021 and bottomed at -$58.8 million in Q1 2022.
  • Average Net Cash Flow over 5 years is -$5.8 million, with a median of -$8.7 million recorded in 2021.
  • Year-over-year, Net Cash Flow plummeted 633.08% in 2022 and then skyrocketed 220.71% in 2024.
  • Sangamo Therapeutics' Net Cash Flow stood at $2.0 million in 2021, then soared by 150.81% to $5.1 million in 2022, then crashed by 348.34% to -$12.7 million in 2023, then surged by 139.2% to $5.0 million in 2024, then tumbled by 293.8% to -$9.6 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$9.6 million, -$9.4 million, and $10.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.